July 11, 2005


VIA FACSIMILE (202) 772-9218
-------------

Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Judiciary Plaza
Washington, D.C. 20549

Attn:    Donald Hunt

         Re:      Paradigm Medical Industries, Inc.
                  Withdrawal of Application for Withdrawal of Registration 
                  Statement on Form SB-2
                  Commission File No. 333-106842

Ladies and Gentlemen:

         Paradigm  Medical  Industries,   Inc.,  a  Delaware   corporation  (the
"Registrant"),  hereby  requests the  Securities  and Exchange  Commission  (the
"Commission")  to consent to the withdrawal of the Application for Withdrawal of
the  Registrant's  Registration  Statement  No.  333-106842,  on Form  SB-2 (the
"Registration Statement"), which was filed with the Commission on June 30, 2005.

         The Registration Statement was filed (i) to register for sale shares of
Registrant's common stock and (ii) to register for resale shares of Registrant's
common stock for certain  shareholders,  optionholders and  warrantholders.  The
Registration  was filed with the  Commission  on February  3, 2005 and  declared
effective  on  February  10,  2005.  In order to reflect and  disclose  material
changes  in  Company's  operations  since  February  3, 2005,  Registrant  filed
Post-Effective  Amendment  No. 1 to the  Registration  Statement on Form SB-2 on
June 29, 2005.

         Registrant  incorrectly  filed an  Application  for  Withdrawal  of the
Registration  Statement  filed on  February 3, 2005.  To remedy  this  incorrect
filing,  Registrant  requests  withdrawal of the  Application  for Withdrawal of
Registration  Statement on Form SB-2, Commission File No. 333-106842,  which was
filed on June 30, 2005.

         Please  direct any questions or comments  regarding  this filing to the
undersigned at (801) 977-8970 or Randall A. Mackey, Esq. at (801) 575-5000.

                                      PARADIGM MEDICAL INDUSTRIES, INC.



                                      By: /s/ John Y. Yoon    
                                         -----------------
                                         John Y. Yoon
                                         President and Chief Executive Officer